参考文献

2020-10-21

1: [Tetrabenazine (tetrabenazine Orphan) orally]. J Pharm Belg. 2014 Dec;(4):49-50. Review. French. PubMed PMID: 25562927.

2: Machida K, Kawakami D, Miki M. [Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement]. Nihon Yakurigaku Zasshi. 2014 Mar;143(3):144-51. Review. Japanese. PubMed PMID: 24614638.

3: Chen JJ, Ondo WG, Dashtipour K, Swope DM. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review. PubMed PMID: 22749259.

4: Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149. Review. PubMed PMID: 22014129.

5: Leung JG, Breden EL. Tetrabenazine for the treatment of tardive dyskinesia. Ann Pharmacother. 2011 Apr;45(4):525-31. doi: 10.1345/aph.1P312. Epub 2011 Apr 12. Review. Erratum in: Ann Pharmacother. 2011 May;45(5):690. PubMed PMID: 21487088.

6: Guay DR. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. doi: 10.1016/j.amjopharm.2010.08.006. Review. PubMed PMID: 20869622.

7: Poon LH, Kang GA, Lee AJ. Role of tetrabenazine for Huntington's disease-associated chorea. Ann Pharmacother. 2010 Jun;44(6):1080-9. doi: 10.1345/aph.1M582. Epub 2010 May 4. Review. PubMed PMID: 20442355.

8: Fasano A, Bentivoglio AR. Tetrabenazine. Expert Opin Pharmacother. 2009 Dec;10(17):2883-96. doi: 10.1517/14656560903386292. Review. PubMed PMID: 19929707.

9: Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine. Consult Pharm. 2009 Jul;24(7):524-37. Review. PubMed PMID: 19689181.

10: Tetrabenazine (Xenazine) for Huntington's chorea. Med Lett Drugs Ther. 2009 Jan 26;51(1304):7-8. Review. PubMed PMID: 19172140.

11: Porta M, Sassi M, Cavallazzi M, Fornari M, Brambilla A, Servello D. Tourette's syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig. 2008;28(7):443-59. Review. PubMed PMID: 18544005.

12: Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother. 2006 Jan;6(1):7-17. Review. PubMed PMID: 16466307.